Navigation Links
Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.
Date:1/31/2011

PRINCETON, N.J., Jan. 31, 2011 /PRNewswire/ -- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry.  The company's logo has been updated to emphasize "Laureate" and to incorporate a laurel wreath, illustrating Laureate Biopharma's reputation for scientific excellence and commitment to delivery.  In addition, the company has established a new homepage (www.lbios.com).  

Laureate Biopharma has been in continuous operation in its Princeton, New Jersey facility since 1981.  Since 1996, Laureate Biopharma has focused exclusively on serving other developers in the biotherapeutics market.  

"We are building on Laureate Biopharma's rich history and adding technologies, capacity and staff, while extending our reputation for quality and delivery," said Michael A. Griffith, Chief Executive Officer.  "This name change, although subtle, speaks to our wealth of experience in protein production and a deep scientific bench, which is unique to the industry."

This name change follows the company's announcement of $20 million in secured capital.  All strategically planned improvements are continuing as previously announced.  These include:

  • Adoption of new quality systems technologies
  • Upgrade of aseptic fill capabilities
  • Upgrade and expansion of protein production facilities and services
  • Expansion of mammalian cell line creation services, and
  • Launch of a contract analytical testing business

For more information related to Laureate Biopharma's capabilities and ongoing improvements please visit them at their new website, www.lbios.com.  

About Laureate Biopharmaceutical
'/>"/>

SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
2. Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals Antibody Therapeutic
3. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
4. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
5. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
6. Thomson Reuters Predicts Nobel Laureates
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
9. Vanda Pharmaceuticals Files Shelf Registration Statement
10. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
11. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... CHICAGO, Ill. , June 1, 2015  AbbVie ... 2015 Healthcare Conference on Thursday, June 4, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:6/1/2015)... BOSTON , June 1, 2015 Symbiotix ... a $2.3 million Phase 2 Small Business Technology Transfer ... (NIH) National Institute of Allergy and Infectious Diseases (NIAID). ... is developing a novel class of molecular therapeutics ... lead clinical candidate, Polysaccharide A (PSA), is the first ...
(Date:6/1/2015)... N.J. , June 1, 2015  Elusys ... and Drug Administration (FDA) has accepted for filing ... Anthim® (obiltoxaximab) for the treatment and prevention of ... submitted on March 20, 2015. Anthim is a ... Stockpile, the U.S. government,s repository of critical medical ...
Breaking Medicine Technology:Symbiotix Biotherapies Announces $2.3 Million Award from NIH's National Institute of Allergy and Infectious Diseases (NIAID) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 3
... NEW YORK, April 18, 2012 Financial executives in ... excise tax and the burden of its related compliance ... bottom lines, according to a survey conducted by KPMG ... of respondents said their companies are already contemplating actions ...
... NEW YORK, April 18, 2012 ... initiates coverage on Pacira Pharmaceuticals ... price target $18.00. ... is a member of the ...
Cached Medicine Technology:KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 2KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 3
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Professional Woman of the ... for leadership in safety, environment, health and emergency response. ... professional women, boasting more than 700,000 members and over ... Lourinda with this important honor,” said NAPW President Star ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Selma Tansey as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in mental ... for professional women, boasting more than 700,000 members and ... present Selma with this important honor," said NAPW President ...
(Date:6/1/2015)... Austin, TX (PRWEB) June 01, 2015 ... LLC, to facilitate their investors IRA transactions. AdvantaIRA Trust, ... , Giving investors the ability to fund positions using ... choice to participate on a project, even if there ... 2. Provide an additional funding source for Carson and ...
(Date:6/1/2015)... Unlike most generator rental companies, which raise their rates by ... when the generator is in standby mode, WPP charges a ... or not. WPP also offers an offsite storage option — ... few hours — for companies that do not have the ... “Even minor business disruptions are very expensive for commercial and ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She constantly ... thought it was just a part of getting older, but ... After going to the doctor, she received a distressing diagnosis: ... might happen to her. , Linda is not alone. As ... each year. Valve disease involves damage to one or more ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3
... The chief executive officer of a health authority in St. ... faulty tests that may have affected the care of ... the Eastern Health Regional Authority agreed that Eastern Health could ... knew about the hormone receptor tests. ,'I regret ...
... agreed on a $5-billion initiative with major banks to retrofit ... first such enterprise to combat climate change. ,Former ... week with a summit in New York attended by mayors ... discuss climate change. ,Clinton's initiative launched on Wednesday ...
... President A.P.J. Abdul Kalam Thursday stressed on the necessity ... to increase neuro activities of mentally challenged people. ... of Manovikas Kendra, a premier rehabilitation and research institute ... going on worldwide and it will take five to ...
... offered their first insights at research on a group ... will serve as models of typical childhood development. ... Health study suggest that healthy children perform better on ... was particularly true among children from low-income families. ...
... found that chemical relaxers used to straighten hair are not ... among African-American women. ,Hair relaxers can enter the ... are not fully monitored by the Food and Drug Administration, ... study named Black Womens Health Study was conducted by a ...
... In order to makeup for the loss of the ... hospitals run by state governments , the railways and ... from them to make them profit making units. ... Hindustan Antibiotics Limited, Bengal Chemicals and Pharmaceuticals Limited, Hindustan ...
Cached Medicine News:Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:World Cities Join Hands to Combat Climate Change 2Health News:Library Of Brains To Aid Study of Brain Development In Children 2Health News:Library Of Brains To Aid Study of Brain Development In Children 3Health News:Hair Relaxers Not Linked With Breast Cancer Risk 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
... SP Surgical Table combines innovation and design ... up to 1,000 lbs. You can safely ... normal and reverse orientation and have virtually ... patients.,The Amsco 3085 SP Table offers the ...
... 1st MPJ IMPLANT SYSTEM is a unique ... of the 1st metatarsal phalangeal joint resulting ... revision of a previous arthroplasty. The ... pain relief, superior function and longevity. ...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
Medicine Products: